Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program
The article presents the results of treatment of patients with systemic lupus erythematosus (SLE), who, due to resistance to traditional regimens, for the first time in the Russian Federation were included in the early access program of the type I interferon inhibitor – anifrolumab. Clinical data an...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
IMA-PRESS LLC
2023-04-01
|
| Series: | Современная ревматология |
| Assuntos: | |
| Acceso en liña: | https://mrj.ima-press.net/mrj/article/view/1412 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|